Is Strategic Purchasing in Iranian Insurance Companies Effective?
Since up to 60 percent of health care expenditures in developing countries are allocated to pharmaceutical products, utilizing this budget in order to supply pharmaceutical products is important. Good Procurement Practice (GPP) with the assistance of various ways of tendering is one of the most cost...
Saved in:
Main Authors: | Hoda Faraji (Author), Abbas Kebriaeezadeh (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors affecting technology commercialization in Iranian knowledge based pharmaceutical companies
by: Ramin Radmanesh, et al.
Published: (2015) -
Priority Setting for Productivity Indices in Iranian Pharmaceutical Companies Introduction
by: Majid Annabi, et al.
Published: (2015) -
Strategic Health Purchasing Progress Mapping: A Spotlight on Ghana's National Health Insurance Scheme
by: Eugenia Amporfu, et al.
Published: (2022) -
Has Strategic Purchasing Led to Improvements in Health Systems? A Narrative Review of Literature on Strategic Purchasing
by: Fred Matovu, et al.
Published: (2022) -
SPARC the Change: What the Strategic Purchasing Africa Resource Center Has Learned about Improving Strategic Health Purchasing in Africa
by: Cheryl Cashin, et al.
Published: (2022)